BioSpace News Archive

According to the report, the global medical education market was valued at ~US$ 32 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030.

According to the report, the global homeopathic product market was valued at US$ 5.6 Bn in 2018 and is projected to expand at a CAGR of ~14% from 2019 to 2027.

The high level disinfection services market has made strides from the constant evolution regulations underpinning human sterility practices and standards have undergone.

Oncolytics Biotech® Inc. announced that the Company will present a corporate overview at the Ladenburg Thalmann Healthcare Conference, which is taking place virtually from July 13-14, 2021.

Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced that the first patient has been dosed in the combination expansion cohort of its ongoing Phase 1 clinical trial evaluating COM701, Compugen’s first-in-class anti-PVRIG antibody, in combination with Opdivo®.

Alkermes plc (Nasdaq: ALKS) today announced the presentation of new health economics and outcomes research related to healthcare resource use (HRU) among veterans with alcohol dependence.

Clover Biopharmaceuticals and Dynavax Technologies Corporation announced the execution of a commercial supply agreement of Dynavax’s CpG 1018™ advanced adjuvant, for use in Clover’s protein-based COVID-19 vaccine candidate, SCB-2019.

Genomic Testing Cooperative, a first-in-class diagnostic company based on a cooperative business model using the most recent advances in NGS technology, announced a collaboration with Elevation Oncology to enhance identification of patients with any solid tumor harboring an NRG1 fusion who may be eligible for enrollment in the Phase 2 CRESTONE study.

Progenity, Inc. announced the appointment of Surbhi Sarna to its board of directors effective July 1, 2021.

Cytokinetics, Incorporated today announced that additional results from GALACTIC-HF were presented at Heart Failure 2021.